Vera Therapeutics share price logo

Vera Therapeutics

NASDAQ: VERA

Mid Cap

$32.27

+1.01

(+3.25%)

as on

Vera Therapeutics Stock Performance

as on August 22, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $31.15
    $32.97
    downward going graph

    3.47%

    Downside

    2.17%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $21.15
    $56.05
    downward going graph

    34.46%

    Downside

    73.69%

    Upside

    downward going graph

Vera Therapeutics share price movements today

Previous Close
$31.26
Open
$31.42
Volume
1.1M
Market Cap
$2.3B
Day's Low - High
$31.15 - $32.97
52 Week Low - High
$21.15 - $56.05

Vera Therapeutics Historical Returns

1 Month Return
-17.84 %
3 Month Return
-15.25 %
1 Year Return
+ 46.84 %
3 Year Return
+ 84.86 %
5 Year Return
+ 86.17 %

Vera Therapeutics Stock Fundamentals & Key Indicators

Check Vera Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.3B

EPS (TTM)

-5.86

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-4.93

Industry PE ratio

-13.046547619047619

PEG Ratio

0.12046058639263438

EBITDA

-390.0M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-84.13%

Vera Therapeutics Stock Valuation

Track how Vera Therapeutics P/E has moved over time to understand its valuation trends.

Vera Therapeutics in the last 5 years

  • Overview

  • Trends

Lowest (-15.38x)

December 31, 2024

Industry (-13.05x)

December 31, 2025

Today (-10.87x)

December 31, 2025

Highest (-5.77x)

December 31, 2022

LowHigh

Today’s Price to Earnings Ratio: -10.87x

Vera Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Vera Therapeutics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$2.3B86.17%-4.930.00%NA
BUY$43.7B669.3%NA0.00%NA
BUY$128.2B154.86%29.8286.04%NA
BUY$25.3B-84.24%-7.98-12.57%NA
BUY$82.7B24.1%19.2484.86%0.44999999999999996%

Stock Returns calculator for Vera Therapeutics Stock including INR - Dollar returns

The Vera Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Vera Therapeutics investment value today

Current value as on today

₹1,64,188

Returns

₹64,188

(+64.19%)

Returns from Vera Therapeutics Stock

₹49,814 (+49.81%)

Dollar Impact

₹14,374 (+14.37%)

Analyst Recommendation on Vera Therapeutics Stock

Based on 14 analysts

BUY

92.86%

Buy

7.14%

Hold

0.00%

Sell

Based on 14 analysts, 92.85714285714286% of analysts recommend a 'BUY' rating for Vera Therapeutics. Average target price of $77.14

Vera Therapeutics Share Price Target

Get share price movements and forecasts by analysts on Vera Therapeutics.

What analysts predicted

58.17%UPSIDE

Target Price

$77.14

Current Price

$32.27

Analyzed by

14 Analysts

Target

$77.14

Vera Therapeutics target price $77.14, a slight upside of 58.17% compared to current price of $32.27. According to 14 analysts rating.

Indian Investors' Interest in Vera Therapeutics Stock

Search interest for Vera Therapeutics Stock has decreased by -82% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-82% versus previous 30 day period

Vera Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
0
-
-
-
-
0
-
1
0
-
Operating Income
-31
-37
-49
-48
-57
-80
-83
-94
-125
-112
EBITDA
-26
-30
-44
-41
-49
-74
-78
-85
-118
-107
Interest Expense
1
1
1
1
1
1
1
5
1
1
Depreciation
0
1
0
0
0
0
0
0
0
0
Income Before Tax
-28
-33
-46
-43
-51
-76
-80
-91
-121
-109
Income Tax Expense
-
-
-
0
-
-
-
0
-
-
Net Income
-28
-33
-46
-43
-51
-76
-80
-91
-121
-109
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Vera Therapeutics Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
Gross Profit
0
0
-
0
-
-
-
Operating Income
-11
-48
-34
-90
-102
-167
-315
EBITDA
-11
-52
-32
-88
-92
-144
-291
Interest Expense
0
0
0
0
3
7
7
Depreciation
0
0
0
0
0
0
0
Income Before Tax
-11
-53
-32
-89
-95
-152
-299
Income Tax Expense
0
0
0
0
0
0
0
Net Income
-11
-53
-32
-89
-95
-152
-299
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Vera Therapeutics Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-28
-33
-46
-43
-51
-76
-80
-91
-121
-109
Operating Cash Flow
-33
-24
-36
-39
-54
-54
-61
-69
-106
-100
Investing Cash Flow
-219
-22
38
-221
15
28
69
80
-137
32
Financing Cash Flow
276
3
0
325
1
20
0
286
3
1
Change in Cash
23
-44
2
65
-37
-5
8
296
-240
-65

Vera Therapeutics Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-11
-53
-32
-89
-95
-152
-299
Operating Cash Flow
-10
-34
-23
-67
-92
-134
-241
Investing Cash Flow
0
0
-4
-70
-39
-425
194
Financing Cash Flow
0
85
53
101
133
606
308
Change in Cash
-10
50
25
-36
1
46
262

Mutual Funds that own Vera Therapeutics Stock

Check out the Mutual Funds with significant holdings in Vera Therapeutics.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
3.634275%
2618980
T. ROWE PRICE HEALTH SCIENCES FUND, INC.
1.714888%
1235806
Fidelity Mt. Vernon Street Trust
1.703235%
1227408
T. ROWE PRICE NEW HORIZONS FUND, INC.
1.559664%
1123946
T. ROWE PRICE INTEGRATED EQUITY FUNDS, INC.
1.033735%
744944

Global Institutional Holdings in Vera Therapeutics

Funds
Holdings
James E. Flynn
5.17%
Vanguard
4.53%
iShares
4.23%
SPDR
4%
Michael Rockefeller
1.39%

Vera Therapeutics News & Key Events

  • img

    Today's Timeline - 07 January

    Wed, 10:59 PM

    -

    Vera Therapeutics shares rose after FDA accepted atacicept BLA for priority review, targeting IgAN treatment.

Insights on Vera Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, VERA stock has moved up by 21.5%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 68.66% of holdings in Mar 2026 quarter

  • imgNO EFFECT

    Retail Holding Unchanged

    img

    Retail Investor holdings remained unchanged at 31.34% of holdings in Mar 2026 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Arvind Ltd has given 221.9% return, outperforming this stock by 156.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 570.7% return, outperforming this stock by 488.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Revolution Medicines, Inc. Common Stock has given 466.0% return, outperforming this stock by 423.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Arvind Ltd has given 82.6% return, outperforming this stock by 59.2%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, VERA stock has moved down by -11.2%

About Vera Therapeutics

Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of transformative treatments for patients with immunological diseases. The company offers atacicept, a fully humanized TACI-Fc fusion protein that binds B-cell activating factor (BAFF) and A proliferation-inducing ligand (APRIL), which is self-administered at home as a subcutaneous injection being evaluated for the treatment of immunoglobulin A nephropathy (IgAN) and other autoimmune kidney diseases. It is also developing MAU868, a human monoclonal antibody for the treatment of BK viremia infections that has completed phase 2 clinical trial; and VT-109, a novel BAFF/APRIL dual-inhibitor B cell maturation antigen (BCMA) molecule to treat B cell mediated autoimmune diseases. The company was formerly known as Trucode Gene Repair, Inc. and changed its name to Vera Therapeutics, Inc. in April 2020. Vera Therapeutics, Inc. was incorporated in 2016 and is headquartered in Brisbane, California.
OrganisationVera Therapeutics
Headquarters2000 Sierra Point Parkway, Brisbane, CA, United States, 94005
IndustryBiotechnology
CEODr. Marshall W. Fordyce M.D.
E-voting on sharesClick here to vote

Key Management of Vera Therapeutics

Name

Title

Dr. Marshall W. Fordyce M.D.

Founder, President, CEO & Director

Dr. Jane Wright-Mitchell J.D., Pharm.D.

Chief Legal Officer & Secretary

Ms. Emma Haywood

Vice President of Marketing

Mr. Joseph R. Young M.B.A.

Senior VP of Finance & Chief Accounting Officer

Ms. S. Sandra Park J.D.

Senior VP of Legal, Healthcare,Commercial Law, Compliance & Operations

Ms. Debra Charlesworth

Vice President of Corporate Communications

Mr. Sean P. Grant M.B.A.

Chief Financial Officer

Mr. David L. Johnson M.B.A.

Chief Opearating Officer

Dr. Robert M. Brenner M.D.

Chief Medical Officer

FAQs

What is Vera Therapeutics share price today?

Vera Therapeutics share price today is $32.27 as on at the close of the market. Vera Therapeutics share today touched a day high of $32.97 and a low of $31.15.

What is the 52 week high and 52 week low for Vera Therapeutics share?

Vera Therapeutics share touched a 52 week high of $56.05 on and a 52 week low of $21.15 on . Vera Therapeutics stock price today i.e. is closed at $32.27,which is 42.43% down from its 52 week high and 52.58% up from its 52 week low.

What is Vera Therapeutics's market capitalisation today?

Vera Therapeutics market capitalisation is $0.00T as on .

How to invest in Vera Therapeutics Stock (VERA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Vera Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Vera Therapeutics Shares that will get you 0.0465 shares as per Vera Therapeutics share price of $32.27 per share as on August 22, 2026 at 8:45 am IST.

What is the minimum amount required to buy Vera Therapeutics Stock (VERA) from India?

Indian investors can start investing in Vera Therapeutics (VERA) shares with as little as ₹95.71 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹957.10 in Vera Therapeutics stock (as per the Rupee-Dollar exchange rate as on ). Based on Vera Therapeutics share’s latest price of $32.27 as on August 22, 2026 at 8:45 am IST, you will get 0.3099 shares of Vera Therapeutics. Learn more about fractional shares .

What are the returns that Vera Therapeutics has given to Indian investors in the last 5 years?

Vera Therapeutics stock has given 86.17% share price returns and 29.17% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?